New York, NY—J. Tomilson Hill, Chair, and Wendy Fisher, President, Solomon R. Guggenheim Foundation, today announced that Frank Yu has been elected to the Board of Trustees. In a joint…
Investors say industry’s fundamentals remain strong. By Brian Gormley (WWW.WSJ.COM)–Initial public offerings by biotechnology companies are slowing after two record-setting years as the poor performance of some recent IPOs combined with economic and geopolitical uncertain-ties have cooled interest…
Three oncology and fibrotic disease programs in clinical development by end of 2022 SAN DIEGO (BUSINESS WIRE) — Endeavor BioMedicines, a clinical-stage biotechnology company targeting the core drivers of terminal…
Led by Kinnevik and Human Capital and joined by Ally Bridge Group, General Catalyst, 7wireVentures and existing Transcarent investors Leading health systems Northwell Health, Intermountain Healthcare, and Rush University Medical…
The most extensive toolbox of proprietary genomic editors in the industry to enable development of curative, next-generation genetic medicines Co-founded by David Walt, Ph.D. and Feng Zhang, Ph.D. CAMBRIDGE, Massachusetts…
Financing accelerates the growth of Shoreline’s pipeline of iPSC-based cell immunotherapies for the treatment of seriously ill patients and enables the buildout of smart manufacturing capabilities SAN DIEGO, Nov. 2, 2021 /PRNewswire/…
Montpellier, France, October 19th, 2021 – Quantum Surgical, an innovative medical robotic company, announced today that it has secured €40 million (US$48 million) of financing. Led by existing key investor Ally…
Proceeds Used to Acquire ClinEdge and Invest Further in Technology & Data Platform September 23, 2021 12:30 PM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Morgan Stanley Expansion Capital and Ally Bridge…
Sonoma Biotherapeutics’ platform and product candidates aim to restore immune system balance through complementary regulatory T cell (Treg) therapy and effector T cell (Teff) conditioning Series B financing comprised of…
Imperative Care to Create Strategic Network of Wholly Owned Development Subsidiaries in Areas of Synergy, Starting with Acquisition of Truvic Medical, Inc., a Peripheral Thrombectomy Innovator July 15, 2021 08:00…
